 | • レポートコード：MRC2-11QY02593 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗レトロウイルス薬のグローバル市場について調査・分析したレポートです。種類別（プロテアーゼ阻害剤、非ヌクレオシド逆転写酵素阻害剤、インテグラーゼ阻害剤、ヌクレオシド類似体・ヌクレオシド逆転写酵素阻害剤）市場規模、用途別（肝炎、HIV / AIDS、ヘルペス、インフルエンザ、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗レトロウイルス薬の競争状況、市場シェア ・世界の抗レトロウイルス薬市場：種類別市場規模 2015年-2020年（プロテアーゼ阻害剤、非ヌクレオシド逆転写酵素阻害剤、インテグラーゼ阻害剤、ヌクレオシド類似体・ヌクレオシド逆転写酵素阻害剤） ・世界の抗レトロウイルス薬市場：種類別市場規模予測 2021年-2026年（プロテアーゼ阻害剤、非ヌクレオシド逆転写酵素阻害剤、インテグラーゼ阻害剤、ヌクレオシド類似体・ヌクレオシド逆転写酵素阻害剤） ・世界の抗レトロウイルス薬市場：用途別市場規模 2015年-2020年（肝炎、HIV / AIDS、ヘルペス、インフルエンザ、その他） ・世界の抗レトロウイルス薬市場：用途別市場規模予測 2021年-2026年（肝炎、HIV / AIDS、ヘルペス、インフルエンザ、その他） ・北米の抗レトロウイルス薬市場分析：米国、カナダ ・ヨーロッパの抗レトロウイルス薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗レトロウイルス薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗レトロウイルス薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗レトロウイルス薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Cardionet、GE Healthcare、Abbott、AstraZeneca、Bristol-Myers-Squibb、Gilead、Cardiac Science Corp.、Cardiocom、Biotelemetry、GlaxoSmithKline、Roche ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Anti-Retroviral Drugs Market
The global Anti-Retroviral Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anti-Retroviral Drugs Scope and Market Size
Anti-Retroviral Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Retroviral Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Retroviral Drugs market is segmented into
Protease Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Integrase Inhibitors
Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
Segment by Application, the Anti-Retroviral Drugs market is segmented into
Hepatitis
HIV/AIDS
Herpes
Influenza
Others
Regional and Country-level Analysis
The Anti-Retroviral Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Retroviral Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Retroviral Drugs Market Share Analysis
Anti-Retroviral Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Retroviral Drugs business, the date to enter into the Anti-Retroviral Drugs market, Anti-Retroviral Drugs product introduction, recent developments, etc.
The major vendors covered:
Cardionet
GE Healthcare
Abbott
AstraZeneca
Bristol-Myers-Squibb
Gilead
Cardiac Science Corp.
Cardiocom
Biotelemetry
GlaxoSmithKline
Roche
1 Study Coverage
1.1 Anti-Retroviral Drugs Product Introduction
1.2 Market Segments
1.3 Key Anti-Retroviral Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Retroviral Drugs Market Size Growth Rate by Type
1.4.2 Protease Inhibitors
1.4.3 Non-Nucleoside Reverse Transcriptase Inhibitors
1.4.4 Integrase Inhibitors
1.4.5 Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
1.5 Market by Application
1.5.1 Global Anti-Retroviral Drugs Market Size Growth Rate by Application
1.5.2 Hepatitis
1.5.3 HIV/AIDS
1.5.4 Herpes
1.5.5 Influenza
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Retroviral Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti-Retroviral Drugs Revenue 2015-2026
2.1.2 Global Anti-Retroviral Drugs Sales 2015-2026
2.2 Global Anti-Retroviral Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Retroviral Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Retroviral Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Retroviral Drugs Competitor Landscape by Players
3.1 Anti-Retroviral Drugs Sales by Manufacturers
3.1.1 Anti-Retroviral Drugs Sales by Manufacturers (2015-2020)
3.1.2 Anti-Retroviral Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Retroviral Drugs Revenue by Manufacturers
3.2.1 Anti-Retroviral Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Retroviral Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Retroviral Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Retroviral Drugs Revenue in 2019
3.2.5 Global Anti-Retroviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Retroviral Drugs Price by Manufacturers
3.4 Anti-Retroviral Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Retroviral Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Retroviral Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Retroviral Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Retroviral Drugs Market Size by Type (2015-2020)
4.1.1 Global Anti-Retroviral Drugs Sales by Type (2015-2020)
4.1.2 Global Anti-Retroviral Drugs Revenue by Type (2015-2020)
4.1.3 Anti-Retroviral Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Retroviral Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Retroviral Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Retroviral Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Retroviral Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Retroviral Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Retroviral Drugs Market Size by Application (2015-2020)
5.1.1 Global Anti-Retroviral Drugs Sales by Application (2015-2020)
5.1.2 Global Anti-Retroviral Drugs Revenue by Application (2015-2020)
5.1.3 Anti-Retroviral Drugs Price by Application (2015-2020)
5.2 Anti-Retroviral Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Retroviral Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Retroviral Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Retroviral Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-Retroviral Drugs by Country
6.1.1 North America Anti-Retroviral Drugs Sales by Country
6.1.2 North America Anti-Retroviral Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Retroviral Drugs Market Facts & Figures by Type
6.3 North America Anti-Retroviral Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-Retroviral Drugs by Country
7.1.1 Europe Anti-Retroviral Drugs Sales by Country
7.1.2 Europe Anti-Retroviral Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Retroviral Drugs Market Facts & Figures by Type
7.3 Europe Anti-Retroviral Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-Retroviral Drugs by Region
8.1.1 Asia Pacific Anti-Retroviral Drugs Sales by Region
8.1.2 Asia Pacific Anti-Retroviral Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Retroviral Drugs Market Facts & Figures by Type
8.3 Asia Pacific Anti-Retroviral Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-Retroviral Drugs by Country
9.1.1 Latin America Anti-Retroviral Drugs Sales by Country
9.1.2 Latin America Anti-Retroviral Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Retroviral Drugs Market Facts & Figures by Type
9.3 Central & South America Anti-Retroviral Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-Retroviral Drugs by Country
10.1.1 Middle East and Africa Anti-Retroviral Drugs Sales by Country
10.1.2 Middle East and Africa Anti-Retroviral Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Retroviral Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Retroviral Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Cardionet
11.1.1 Cardionet Corporation Information
11.1.2 Cardionet Description and Business Overview
11.1.3 Cardionet Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cardionet Anti-Retroviral Drugs Products Offered
11.1.5 Cardionet Related Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Corporation Information
11.2.2 GE Healthcare Description and Business Overview
11.2.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GE Healthcare Anti-Retroviral Drugs Products Offered
11.2.5 GE Healthcare Related Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Description and Business Overview
11.3.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abbott Anti-Retroviral Drugs Products Offered
11.3.5 Abbott Related Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Corporation Information
11.4.2 AstraZeneca Description and Business Overview
11.4.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.4.4 AstraZeneca Anti-Retroviral Drugs Products Offered
11.4.5 AstraZeneca Related Developments
11.5 Bristol-Myers-Squibb
11.5.1 Bristol-Myers-Squibb Corporation Information
11.5.2 Bristol-Myers-Squibb Description and Business Overview
11.5.3 Bristol-Myers-Squibb Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bristol-Myers-Squibb Anti-Retroviral Drugs Products Offered
11.5.5 Bristol-Myers-Squibb Related Developments
11.6 Gilead
11.6.1 Gilead Corporation Information
11.6.2 Gilead Description and Business Overview
11.6.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Gilead Anti-Retroviral Drugs Products Offered
11.6.5 Gilead Related Developments
11.7 Cardiac Science Corp.
11.7.1 Cardiac Science Corp. Corporation Information
11.7.2 Cardiac Science Corp. Description and Business Overview
11.7.3 Cardiac Science Corp. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Cardiac Science Corp. Anti-Retroviral Drugs Products Offered
11.7.5 Cardiac Science Corp. Related Developments
11.8 Cardiocom
11.8.1 Cardiocom Corporation Information
11.8.2 Cardiocom Description and Business Overview
11.8.3 Cardiocom Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Cardiocom Anti-Retroviral Drugs Products Offered
11.8.5 Cardiocom Related Developments
11.9 Biotelemetry
11.9.1 Biotelemetry Corporation Information
11.9.2 Biotelemetry Description and Business Overview
11.9.3 Biotelemetry Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biotelemetry Anti-Retroviral Drugs Products Offered
11.9.5 Biotelemetry Related Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Description and Business Overview
11.10.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.10.4 GlaxoSmithKline Anti-Retroviral Drugs Products Offered
11.10.5 GlaxoSmithKline Related Developments
11.1 Cardionet
11.1.1 Cardionet Corporation Information
11.1.2 Cardionet Description and Business Overview
11.1.3 Cardionet Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cardionet Anti-Retroviral Drugs Products Offered
11.1.5 Cardionet Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-Retroviral Drugs Market Estimates and Projections by Region
12.1.1 Global Anti-Retroviral Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Retroviral Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Retroviral Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Retroviral Drugs Sales Forecast (2021-2026)
12.2.2 North America: Anti-Retroviral Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Retroviral Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Retroviral Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Retroviral Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Retroviral Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Retroviral Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Retroviral Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Retroviral Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Retroviral Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Retroviral Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Retroviral Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Retroviral Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Retroviral Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Retroviral Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Retroviral Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Retroviral Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Retroviral Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Retroviral Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-Retroviral Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Retroviral Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anti-Retroviral Drugs Market Segments
Table 2. Ranking of Global Top Anti-Retroviral Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Retroviral Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Protease Inhibitors
Table 5. Major Manufacturers of Non-Nucleoside Reverse Transcriptase Inhibitors
Table 6. Major Manufacturers of Integrase Inhibitors
Table 7. Major Manufacturers of Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
Table 8. Global Anti-Retroviral Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Anti-Retroviral Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Anti-Retroviral Drugs Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Anti-Retroviral Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Anti-Retroviral Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Anti-Retroviral Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Anti-Retroviral Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Anti-Retroviral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Anti-Retroviral Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Retroviral Drugs as of 2019)
Table 17. Anti-Retroviral Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Anti-Retroviral Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Anti-Retroviral Drugs Price (2015-2020) (USD/Pcs)
Table 20. Anti-Retroviral Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Anti-Retroviral Drugs Product Type
Table 22. Date of International Manufacturers Enter into Anti-Retroviral Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-Retroviral Drugs Sales by Type (2015-2020) (K Pcs)
Table 25. Global Anti-Retroviral Drugs Sales Share by Type (2015-2020)
Table 26. Global Anti-Retroviral Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Anti-Retroviral Drugs Revenue Share by Type (2015-2020)
Table 28. Anti-Retroviral Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Anti-Retroviral Drugs Sales by Application (2015-2020) (K Pcs)
Table 30. Global Anti-Retroviral Drugs Sales Share by Application (2015-2020)
Table 31. North America Anti-Retroviral Drugs Sales by Country (2015-2020) (K Pcs)
Table 32. North America Anti-Retroviral Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Anti-Retroviral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Anti-Retroviral Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Anti-Retroviral Drugs Sales by Type (2015-2020) (K Pcs)
Table 36. North America Anti-Retroviral Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Anti-Retroviral Drugs Sales by Application (2015-2020) (K Pcs)
Table 38. North America Anti-Retroviral Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Anti-Retroviral Drugs Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Anti-Retroviral Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Anti-Retroviral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Anti-Retroviral Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Anti-Retroviral Drugs Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Anti-Retroviral Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Anti-Retroviral Drugs Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Anti-Retroviral Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Anti-Retroviral Drugs Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Anti-Retroviral Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Anti-Retroviral Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Anti-Retroviral Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Anti-Retroviral Drugs Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Anti-Retroviral Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Anti-Retroviral Drugs Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Anti-Retroviral Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Anti-Retroviral Drugs Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Anti-Retroviral Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Anti-Retroviral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Anti-Retroviral Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Anti-Retroviral Drugs Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Anti-Retroviral Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Anti-Retroviral Drugs Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Anti-Retroviral Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Anti-Retroviral Drugs Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Anti-Retroviral Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Anti-Retroviral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Anti-Retroviral Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Anti-Retroviral Drugs Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Anti-Retroviral Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Anti-Retroviral Drugs Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Anti-Retroviral Drugs Sales Market Share by Application (2015-2020)
Table 71. Cardionet Corporation Information
Table 72. Cardionet Description and Major Businesses
Table 73. Cardionet Anti-Retroviral Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Cardionet Product
Table 75. Cardionet Recent Development
Table 76. GE Healthcare Corporation Information
Table 77. GE Healthcare Description and Major Businesses
Table 78. GE Healthcare Anti-Retroviral Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. GE Healthcare Product
Table 80. GE Healthcare Recent Development
Table 81. Abbott Corporation Information
Table 82. Abbott Description and Major Businesses
Table 83. Abbott Anti-Retroviral Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Abbott Product
Table 85. Abbott Recent Development
Table 86. AstraZeneca Corporation Information
Table 87. AstraZeneca Description and Major Businesses
Table 88. AstraZeneca Anti-Retroviral Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. AstraZeneca Product
Table 90. AstraZeneca Recent Development
Table 91. Bristol-Myers-Squibb Corporation Information
Table 92. Bristol-Myers-Squibb Description and Major Businesses
Table 93. Bristol-Myers-Squibb Anti-Retroviral Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Bristol-Myers-Squibb Product
Table 95. Bristol-Myers-Squibb Recent Development
Table 96. Gilead Corporation Information
Table 97. Gilead Description and Major Businesses
Table 98. Gilead Anti-Retroviral Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Gilead Product
Table 100. Gilead Recent Development
Table 101. Cardiac Science Corp. Corporation Information
Table 102. Cardiac Science Corp. Description and Major Businesses
Table 103. Cardiac Science Corp. Anti-Retroviral Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Cardiac Science Corp. Product
Table 105. Cardiac Science Corp. Recent Development
Table 106. Cardiocom Corporation Information
Table 107. Cardiocom Description and Major Businesses
Table 108. Cardiocom Anti-Retroviral Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. Cardiocom Product
Table 110. Cardiocom Recent Development
Table 111. Biotelemetry Corporation Information
Table 112. Biotelemetry Description and Major Businesses
Table 113. Biotelemetry Anti-Retroviral Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Biotelemetry Product
Table 115. Biotelemetry Recent Development
Table 116. GlaxoSmithKline Corporation Information
Table 117. GlaxoSmithKline Description and Major Businesses
Table 118. GlaxoSmithKline Anti-Retroviral Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. GlaxoSmithKline Product
Table 120. GlaxoSmithKline Recent Development
Table 121. Roche Corporation Information
Table 122. Roche Description and Major Businesses
Table 123. Roche Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 124. Roche Product
Table 125. Roche Recent Development
Table 126. Global Anti-Retroviral Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 127. Global Anti-Retroviral Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Anti-Retroviral Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Anti-Retroviral Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Anti-Retroviral Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 131. North America: Anti-Retroviral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Anti-Retroviral Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 133. Europe: Anti-Retroviral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Anti-Retroviral Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 135. Asia Pacific: Anti-Retroviral Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Anti-Retroviral Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 137. Latin America: Anti-Retroviral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Anti-Retroviral Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 139. Middle East and Africa: Anti-Retroviral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Anti-Retroviral Drugs Players
Table 144. Anti-Retroviral Drugs Customers List
Table 145. Anti-Retroviral Drugs Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Retroviral Drugs Product Picture
Figure 2. Global Anti-Retroviral Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Protease Inhibitors Product Picture
Figure 4. Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 5. Integrase Inhibitors Product Picture
Figure 6. Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 7. Global Anti-Retroviral Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hepatitis
Figure 9. HIV/AIDS
Figure 10. Herpes
Figure 11. Influenza
Figure 12. Others
Figure 13. Anti-Retroviral Drugs Report Years Considered
Figure 14. Global Anti-Retroviral Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Anti-Retroviral Drugs Sales 2015-2026 (K Pcs)
Figure 16. Global Anti-Retroviral Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Anti-Retroviral Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Anti-Retroviral Drugs Sales Market Share by Region in 2019
Figure 19. Global Anti-Retroviral Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Anti-Retroviral Drugs Revenue Market Share by Region in 2019
Figure 21. Global Anti-Retroviral Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Anti-Retroviral Drugs Revenue in 2019
Figure 23. Anti-Retroviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Anti-Retroviral Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Anti-Retroviral Drugs Sales Market Share by Type in 2019
Figure 26. Global Anti-Retroviral Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Anti-Retroviral Drugs Revenue Market Share by Type in 2019
Figure 28. Global Anti-Retroviral Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Anti-Retroviral Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Anti-Retroviral Drugs Sales Market Share by Application in 2019
Figure 31. Global Anti-Retroviral Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Anti-Retroviral Drugs Revenue Market Share by Application in 2019
Figure 33. North America Anti-Retroviral Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Anti-Retroviral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Anti-Retroviral Drugs Sales Market Share by Country in 2019
Figure 36. North America Anti-Retroviral Drugs Revenue Market Share by Country in 2019
Figure 37. U.S. Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Anti-Retroviral Drugs Market Share by Type in 2019
Figure 42. North America Anti-Retroviral Drugs Market Share by Application in 2019
Figure 43. Europe Anti-Retroviral Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Anti-Retroviral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Anti-Retroviral Drugs Sales Market Share by Country in 2019
Figure 46. Europe Anti-Retroviral Drugs Revenue Market Share by Country in 2019
Figure 47. Germany Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Anti-Retroviral Drugs Market Share by Type in 2019
Figure 58. Europe Anti-Retroviral Drugs Market Share by Application in 2019
Figure 59. Asia Pacific Anti-Retroviral Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Anti-Retroviral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Anti-Retroviral Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Anti-Retroviral Drugs Revenue Market Share by Region in 2019
Figure 63. China Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Anti-Retroviral Drugs Market Share by Type in 2019
Figure 86. Asia Pacific Anti-Retroviral Drugs Market Share by Application in 2019
Figure 87. Latin America Anti-Retroviral Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Anti-Retroviral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Anti-Retroviral Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Anti-Retroviral Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Anti-Retroviral Drugs Market Share by Type in 2019
Figure 98. Latin America Anti-Retroviral Drugs Market Share by Application in 2019
Figure 99. Middle East and Africa Anti-Retroviral Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Anti-Retroviral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Anti-Retroviral Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Anti-Retroviral Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Anti-Retroviral Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Anti-Retroviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Anti-Retroviral Drugs Market Share by Type in 2019
Figure 110. Middle East and Africa Anti-Retroviral Drugs Market Share by Application in 2019
Figure 111. North America Anti-Retroviral Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Anti-Retroviral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Anti-Retroviral Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Anti-Retroviral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Anti-Retroviral Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Anti-Retroviral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Anti-Retroviral Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Anti-Retroviral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Anti-Retroviral Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Anti-Retroviral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
HIV薬の世界市場（～2026年） HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population. One…- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 抗高血圧薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-Hypertensive Drugs Market The global Anti-Hypertensive Drugs market size is projected to reach US$ 40970 million by 2026, from US$ 40270 million in 2020, at a CAGR of 1.6%% during 2021-2026. Global Anti-Hypertensive Drugs Scope and Market Size Anti-Hypertens…
- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…
- ヒト免疫不全ウイルス（HIV）-1治療薬の世界市場（～2026年） The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and can…